Terms: = Sarcomas AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Treatment
67 results:
1. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
2. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs/AKT/NRF2 pathway and reducing PD-L1 expression to attenuate immune evasion.
Zhang Y; Shen G; Meng T; Lv Z; Li X; Li J; Li K
Int Immunopharmacol; 2023 Dec; 125(Pt B):111181. PubMed ID: 37951196
[TBL] [Abstract] [Full Text] [Related]
3. A prospective cohort study of timp1 as prognostic biomarker in gastric and colon cancer.
Macedo FC; Cunha N; Pereira TC; Soares RF; Monteiro AR; Bonito N; Valido F; Sousa G
Chin Clin Oncol; 2022 Dec; 11(6):43. PubMed ID: 36509552
[TBL] [Abstract] [Full Text] [Related]
4. The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient-derived primary culture case series in tridimensional and zebrafish models.
De Vita A; Recine F; Miserocchi G; Pieri F; Spadazzi C; Cocchi C; Vanni S; Liverani C; Farnedi A; Fabbri F; Fausti V; Casadei R; Brandolini F; Ercolani G; Cavaliere D; Bongiovanni A; Riva N; Gurrieri L; Di Menna G; Calpona S; Debonis SA; Mercatali L; Ibrahim T
J Exp Clin Cancer Res; 2021 May; 40(1):165. PubMed ID: 33975637
[TBL] [Abstract] [Full Text] [Related]
5. Eicosapentaenoic Acid Inhibits
Chiu CF; Hsu MI; Yeh HY; Park JM; Shen YS; Tung TH; Huang JJ; Wu HT; Huang SY
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801246
[TBL] [Abstract] [Full Text] [Related]
6. Inhibitory effects on chondrosarcoma cell metastasis by Senna alata extract.
Kittiwattanokhun A; Samosorn S; Innajak S; Watanapokasin R
Biomed Pharmacother; 2021 May; 137():111337. PubMed ID: 33582453
[TBL] [Abstract] [Full Text] [Related]
7. Effect of Lapachol on the Inhibition of Matrix Metalloproteinase Related to the Invasion of Human Fibrosarcoma Cells.
Kim J; Kim MM
Curr Mol Pharmacol; 2021 Oct; 14(4):620-626. PubMed ID: 33019942
[TBL] [Abstract] [Full Text] [Related]
8. Pazopanib-related secondary polycythemia in metastatic myxofibrosarcoma: A case report and review of the literature.
Fanelli M; Caputo F; Cerma K; Gelsomino F; Bari A; Dominici M; Pozzi S
J Oncol Pharm Pract; 2021 Apr; 27(3):766-770. PubMed ID: 32838682
[TBL] [Abstract] [Full Text] [Related]
9. Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1.
Li S; Pei Y; Wang W; Liu F; Zheng K; Zhang X
Biomed Pharmacother; 2019 Jun; 114():108839. PubMed ID: 30978523
[TBL] [Abstract] [Full Text] [Related]
10. The specific RIP1 inhibitor necrostatin-1 ameliorated degradation of ECM in human SW1353 cells.
Hu X; Zhu Y; Wang J; Tang J; Yu H; Xie Y; Dong Q
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1169-S1175. PubMed ID: 30604633
[TBL] [Abstract] [Full Text] [Related]
11. Diazoxide ameliorates severity of experimental osteoarthritis by activating autophagy via modulation of the osteoarthritis-related biomarkers.
Meng Z; Shen B; Gu Y; Wu Z; Yao J; Bian Y; Zeng D; Chen K; Cheng S; Fu J; Peng L; Zhao Y
J Cell Biochem; 2018 Nov; 119(11):8922-8936. PubMed ID: 29953665
[TBL] [Abstract] [Full Text] [Related]
12. Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression.
Tsai CH; Yang DY; Lin CY; Chen TM; Tang CH; Huang YL
Mol Oncol; 2017 Oct; 11(10):1380-1398. PubMed ID: 28672103
[TBL] [Abstract] [Full Text] [Related]
13. Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation.
Sandri S; Faião-Flores F; Tiago M; Pennacchi PC; Massaro RR; Alves-Fernandes DK; Berardinelli GN; Evangelista AF; de Lima Vazquez V; Reis RM; Maria-Engler SS
Pharmacol Res; 2016 Sep; 111():523-533. PubMed ID: 27436149
[TBL] [Abstract] [Full Text] [Related]
14. Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications.
Poniewierska-Baran A; Suszynska M; Sun W; Abdelbaset-Ismail A; Schneider G; Barr FG; Ratajczak MZ
Int J Oncol; 2015 Nov; 47(5):1989-97. PubMed ID: 26412593
[TBL] [Abstract] [Full Text] [Related]
15. Serum markers in early-stage and locally advanced melanoma.
Lugowska I; Kowalska M; Fuksiewicz M; Kotowicz B; Mierzejewska E; Koseła-Paterczyk H; Szamotulska K; Rutkowski P
Tumour Biol; 2015 Nov; 36(11):8277-85. PubMed ID: 26002577
[TBL] [Abstract] [Full Text] [Related]
16. Effect of pulsed electromagnetic field on MMP-9 and timp-1 levels in chondrosarcoma cells stimulated with IL-1β.
Caliskan SG; Bilgin MD; Kozaci LD
Asian Pac J Cancer Prev; 2015; 16(7):2701-5. PubMed ID: 25854350
[TBL] [Abstract] [Full Text] [Related]
17. The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration.
Su X; Tanalgo P; Bustos M; Dass CR
Curr Drug Targets; 2018; 19(5):479-486. PubMed ID: 25563592
[TBL] [Abstract] [Full Text] [Related]
18. Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression.
Zhang J; Zhu X; Li H; Li B; Sun L; Xie T; Zhu T; Zhou H; Ye Z
Int Immunopharmacol; 2015 Jan; 24(1):50-8. PubMed ID: 25479727
[TBL] [Abstract] [Full Text] [Related]
19. Deguelin inhibits the migration and invasion of U-2 OS human osteosarcoma cells via the inhibition of matrix metalloproteinase-2/-9 in vitro.
Shang HS; Chang JB; Lin JH; Lin JP; Hsu SC; Liu CM; Liu JY; Wu PP; Lu HF; Au MK; Chung JG
Molecules; 2014 Oct; 19(10):16588-608. PubMed ID: 25322282
[TBL] [Abstract] [Full Text] [Related]
20. Antiangiogenic activity of trabectedin in myxoid liposarcoma: involvement of host timp-1 and timp-2 and tumor thrombospondin-1.
Dossi R; Frapolli R; Di Giandomenico S; Paracchini L; Bozzi F; Brich S; Castiglioni V; Borsotti P; Belotti D; Uboldi S; Sanfilippo R; Erba E; Giavazzi R; Marchini S; Pilotti S; D'Incalci M; Taraboletti G
Int J Cancer; 2015 Feb; 136(3):721-9. PubMed ID: 24917554
[TBL] [Abstract] [Full Text] [Related]
[Next]
